Cargando…
Discovering potent inhibitors against the Mpro of the SARS-CoV-2. A medicinal chemistry approach
The global pandemic caused by a single-stranded RNA (ssRNA) virus known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still at its peak, with new cases being reported daily. Although the vaccines have been administered on a massive scale, the frequent mutations in the viral...
Autores principales: | Mehmood, Aamir, Nawab, Sadia, Wang, Yanjing, Chandra Kaushik, Aman, Wei, Dong-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789387/ https://www.ncbi.nlm.nih.gov/pubmed/35123137 http://dx.doi.org/10.1016/j.compbiomed.2022.105235 |
Ejemplares similares
-
Mutational Impacts on the N and C Terminal Domains
of the MUC5B Protein: A Transcriptomics and Structural Biology Study
por: Mehmood, Aamir, et al.
Publicado: (2023) -
Targeting omicron and other reported SARS-CoV-2 lineages by potent inhibitors of main protease 3CL Mpro: Molecular simulation analysis
por: Saeed, Aamir, et al.
Publicado: (2022) -
Advances in the Development of SARS-CoV-2 Mpro Inhibitors
por: Agost-Beltrán, Laura, et al.
Publicado: (2022) -
Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro
por: Papaj, Katarzyna, et al.
Publicado: (2021) -
Binding of inhibitors to the monomeric and dimeric SARS-CoV-2 Mpro
por: Tam, Nguyen Minh, et al.
Publicado: (2021)